Haier Biomedical has introduced a range of innovative, automated cold storage solutions aimed at enhancing biobanking and laboratory efficiency during two prominent global trade fairs.
At Europe Biobank Week 2026 in Prague and Interphex Week Tokyo 2026, Haier Biomedical showcased its commitment to low-carbon, high-efficiency technologies tailored for the biobanking and pharmaceutical sectors. The company emphasized its localized research and development efforts, which are crucial for meeting specific regional needs. This strategy marks a shift from merely exporting products to integrating ecosystems that support sustainable growth.
One of the standout products unveiled is an automated storage system designed for preserving biological samples at ultra-low temperatures of -80°C. This system accommodates a wide range of storage capacities, from 50,000 to over 200,000 samples, and is equipped with AI-driven monitoring capabilities. Such features ensure temperature consistency and sample safety, addressing the unique requirements of European biobanks.
In Tokyo, Haier Biomedical introduced the DWL368BPST ultra-low temperature freezer, optimized for the spatial constraints of Japanese laboratories. This model boasts significant improvements, including enhanced energy efficiency and quieter operation, further solidifying Haier's role as a key player in advancing life sciences infrastructure. By fostering collaborations with academic and research institutions, the company is positioning itself as a trusted partner in the global life sciences ecosystem.